Nothing Special   »   [go: up one dir, main page]

GB0705803D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0705803D0
GB0705803D0 GBGB0705803.5A GB0705803A GB0705803D0 GB 0705803 D0 GB0705803 D0 GB 0705803D0 GB 0705803 A GB0705803 A GB 0705803A GB 0705803 D0 GB0705803 D0 GB 0705803D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0705803.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0705803.5A priority Critical patent/GB0705803D0/en
Publication of GB0705803D0 publication Critical patent/GB0705803D0/en
Priority to PCT/EP2008/053354 priority patent/WO2008116816A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0705803.5A 2007-03-26 2007-03-28 Novel compounds Ceased GB0705803D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0705803.5A GB0705803D0 (en) 2007-03-28 2007-03-28 Novel compounds
PCT/EP2008/053354 WO2008116816A1 (en) 2007-03-26 2008-03-20 Combination of cb2 ligand and paracetamol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0705803.5A GB0705803D0 (en) 2007-03-28 2007-03-28 Novel compounds

Publications (1)

Publication Number Publication Date
GB0705803D0 true GB0705803D0 (en) 2007-05-02

Family

ID=38024883

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0705803.5A Ceased GB0705803D0 (en) 2007-03-26 2007-03-28 Novel compounds

Country Status (2)

Country Link
GB (1) GB0705803D0 (en)
WO (1) WO2008116816A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1392679B1 (en) * 2001-05-10 2005-11-02 Solvay Pharmaceuticals GmbH Novel 1-amidomethylcarbonyl-piperidine derivatives, method for the production thereof and medicament containing said compounds
WO2009124553A2 (en) * 2008-04-09 2009-10-15 Neurokey A/S Use of hypothermia inducing drugs
CN102378757A (en) 2009-03-30 2012-03-14 安斯泰来制药株式会社 Pyrimidine compound
TWI482622B (en) * 2010-07-29 2015-05-01 Astellas Pharma Inc Shrinkage pyridine compounds
PL3027600T3 (en) * 2013-07-31 2022-08-08 Novartis Ag 1,4-disubstituted pyridazine derivatives and their use for treating smn-deficiency-related conditions
JP7212781B2 (en) 2018-12-19 2023-01-25 ディスアーム セラピューティクス, インコーポレイテッド Inhibitors of SARM1 in combination with neuroprotective agents
CN111777593B (en) * 2019-04-03 2024-07-23 南京天印健华医药科技有限公司 Novel compounds as inhibitors of rearrangement kinase during transfection
CN112661688B (en) * 2019-10-16 2023-04-07 杭州迪克科技有限公司 Synthetic method of non-steroidal anti-inflammatory drug tolmetin
CN115282279B (en) * 2022-08-08 2024-03-12 暨南大学附属第一医院(广州华侨医院) Application of CNR2 as sepsis acute lung injury treatment target through mediating DCs maturation and function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27939A1 (en) * 2002-08-21 2004-03-31 Glaxo Group Ltd COMPOUNDS
GB0402355D0 (en) * 2004-02-03 2004-03-10 Glaxo Group Ltd Novel compounds
CA2569887A1 (en) * 2004-06-09 2005-12-22 Glaxo Group Limited Pyrrolopyridine derivatives
JP2009504587A (en) * 2005-08-09 2009-02-05 グラクソ グループ リミテッド Imidazopyridine derivatives as nannabinoid receptor ligands

Also Published As

Publication number Publication date
WO2008116816A1 (en) 2008-10-02

Similar Documents

Publication Publication Date Title
GB0710528D0 (en) Novel compounds
EP2152081A4 (en) Novel compounds
GB0712888D0 (en) Novel compounds
EP2146745A4 (en) Novel compounds
GB0705882D0 (en) Novel compounds
GB0710865D0 (en) Novel compounds
GB0706630D0 (en) Novel compounds
GB0705803D0 (en) Novel compounds
GB0708858D0 (en) Novel compounds
GB0710863D0 (en) Novel compounds
GB0711521D0 (en) Novel compounds
GB0712392D0 (en) Novel compounds
GB0703973D0 (en) Novel compounds
GB0703402D0 (en) Novel compounds
GB0708222D0 (en) Novel compounds
GB0703631D0 (en) Novel compounds
GB0703677D0 (en) Novel compounds
GB0703404D0 (en) Novel compounds
GB0704012D0 (en) Novel compounds
GB0704088D0 (en) Novel compounds
GB0704324D0 (en) Novel compounds
GB0704766D0 (en) Novel compounds
GB0705263D0 (en) Novel compounds
GB0703397D0 (en) Novel compounds
GB0703387D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)